The systemic vasculitides are a group of uncommon conditions characterized by inflammation and necrosis of blood vessel walls. Some of these syndromes are also characterized by the presence of antineutrophil cytoplasmic antibodies (ANCA).
| Test Name and Number | Recommended Use | Limitations | Follow Up |
|---|---|---|---|
| Anti-Neutrophil Cytoplasmic Antibody with Reflex to Titer and MPO/PR-3 Antibodies 2002068 Method: Semi-Quantitative Indirect Fluorescent Antibody/Semi-Quantitative Multiplex Bead Assay |
Differentially diagnose systemic vasculitic syndromes, such as
Monitor treatment of Wegener granulomatosis If screen is positive, titer and MPO/PR-3 antibodies testing will be added to aid in antibody determination |
Cross-reaction may occur with cationic protein 57 (CAP 57), cathepsin G, elastase, lactoferrin and other lysosomal proteins |
Test for specific disease identification including serum testing and biopsy of involved site |
| Urinalysis, Complete 0020350 Method: Reflectance Spectrophotometry/Microscopy |
Determine symptoms involved in vasculitic-like infections |
||
| Sedimentation Rate, Westergren (ESR) 0040325 Method: Visual Identification |
Determine symptoms involved in vasculitic-like infections |
||
| C-Reactive Protein 0050180 Method: Quantitative Immunoturbidimetry |
Nonspecific test to check for inflammation |
||
| CBC with Platelet Count and Automated Differential 0040003 Method: Automated Cell Count/Differential |
Monitor treatment of vasculitis | ||
| Hepatic Function Panel 0020416 Method: Quantitative Enzymatic/Quantitative Spectrophotometry |
Monitor treatment of vasculitis Panel includes bilirubin direct; bilirubin total (serum or plasma), alkaline phosphatase, aspartate aminotransferase, alanine aminotransferase, protein total (serum or plasma), albumin (serum or plasma) |
||
| Renal Function Panel 0020144 Method: Quantitative Chemiluminescent Immunoassay/Quantitative Enzyme-Linked Immunosorbent Assay |
Monitor treatment of vasculitis |